pillbase.ru

Бонспри®

Active substance: ofatumumab

раствор для подкожного введения, 20 мг, 0.4 мл (original in Russian, GRLS)

RussiaActive

Marketing holder: Новартис Оверсиз Инвестментс АГ

Verified 2026-10-09 · GRLS (Russian state register)

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 1
  • KESIMPTA
    INJECTION, SOLUTION · OFATUMUMAB 20 mg/.4mL
    0078-1007
    Novartis Pharmaceuticals Corporation
EU 2
  • Kesimpta
    ofatumumab
    EMEA/H/C/005410
    Novartis Europharm Limited
  • Arzerra
    ofatumumab
    EMEA/H/C/001131
    Novartis Europharm Ltd
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-3ecd-7542-a898-23d52406cade,01a120c4-b4cb-771b-84fc-bf10a110e44e;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12091-6cd9-737f-a31d-53b0f606dfdc;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
ЛП-№(001332)-(РГ-RU)
Registration status
Active
Dispensing
Prescription only
Release forms
раствор для подкожного введения, 20 мг, 0.4 мл - шприцы - пачки картонные - По рецепту; (original in Russian, GRLS)
Sources
  • product · GRLS (Russian state register) · ЛП-№(001332)-(РГ-RU) · Verified 2026-10-09
  • registration_status · GRLS (Russian state register) · ЛП-№(001332)-(РГ-RU) · Verified 2026-10-09
  • ingredients.0 · GRLS (Russian state register) · ЛП-№(001332)-(РГ-RU) · Verified 2026-10-09